Content
05/08/2025
Houston, TX USA
PATH EX
completed $5 million Venture Round funding. Investors include
IAG Capital Partners (lead), TMC Venture Fund, Fitz Gate Ventures.
About
Our novel technology aids in the rapid diagnosis and treatment of sepsis. We believe that blood born infections are an archaic problem that needs to be fought through novel solutions.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
